Is a Hemp Regulation Shift Coming?
On June 24, the White House Office of Management and Budget sent a letter to House leadership with a straightforward ask: pass a hemp regulatory package, or delay the November 12 recriminalization deadline. That sentence is worth sitting with for a moment, because ninety days ago the posture from the same administration was closer to the opposite.
This is not a reversal. It is something more useful: an acknowledgment that prohibition is not, in fact, the endgame. The administration that recently claimed authority to dismantle the intoxicating hemp market is now asking Congress to build a framework for it instead. For operators who have spent the last two years building toward a workable standard rather than betting on a ban, that shift is meaningful.
The structural story is distribution, not dosage
The regulatory mechanism taking shape alongside it is Rep. Andy Barr's Lawful Hemp Protection Act (introduced as Amendment No. 54 to H.R. 8646, the Agriculture, Rural Development, Food and Drug Administration and Related Agency Appropriations Act of 2027). The bill would route hemp-derived beverages through the licensed three-tier alcohol distribution system, with a finished-product THC threshold as the compliance baseline.
Most of the conversation in the trade press has focused on the milligram cap. That's the wrong place to focus. The distribution requirement is the structural story. Treating low-dose hemp beverages as an adult beverage category at the wholesaler level, rather than a gray-market SKU moving through unregulated channels, is what determines whether this category scales with any discipline at all. Three-tier isn't a perfect system, but it is a system. Brands and operators who have been preparing for that kind of infrastructure are in a different position than the ones who haven't.
Two tracks, two political coalitions
The useful contradiction running underneath all of this landed on June 29, when the DEA opened its Schedule III hearing for marijuana. The federal government is, in the same week, loosening its posture on marijuana while tightening pressure on low-dose hemp drinks that produce a fraction of the intoxication. These two tracks are not being driven by the same scientific logic. They are being driven by different political coalitions with different timelines and different incentives. Operators trying to read the regulatory environment forward should hold that distinction clearly: what is happening is political sorting, not scientific sorting. Understanding which track your product sits on, and why, matters more right now than parsing any individual bill.
Who shows up with standing
The practical read for brands building in this space: the window to shape what the standard looks like is not closed, but it is narrowing. The administration has signaled it wants a framework. The Barr bill offers one version of what that framework could be. There will be others. The brands that have been operating with formulation discipline, age verification, responsible dosing claims, and a credible retail strategy are the ones who show up to that conversation with standing. The ones who built around regulatory ambiguity as a feature are now exposed by the same ambiguity they were relying on.
Direction of travel
None of this resolves in a straight line. The DEA hearing runs through summer. The November deadline may slip. Specific milligram caps are still being negotiated. But the direction of travel this week was clearer than it has been in some time, and it pointed toward regulation rather than prohibition.
The operators who built to that standard are the ones who will be standing when it arrives.
~
Evan Eneman is the founder of CPG and hospitality consulting firm Sands Lane, beverage advisory and operating platform Harmony Craft Beverages, and co-founder and CEO of Iconic Tonics, a functional beverage portfolio in partnership with Snoop Dogg. He has been building at the intersection of culture, content, and commerce in the cannabis and functional wellness space since 2014.
